Lord Scriven – 2016 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Lord Scriven on 2016-03-22.
To ask Her Majesty’s Government what assessment they have made of the decision by NHS England not to provide Truvada on prescription as a pre-exposure prophylaxis in the treatment and prevention of HIV.
Lord Prior of Brampton
NHS England does not now consider pre-exposure prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) is suitable for prioritisation of specialised commissioning spend as it is a preventative measure. However given the potential benefits in this area, NHS England is keen to build on the work to date and will be making available up to £2 million over the next two years to run a number of early implementer test sites. These will be undertaken in conjunction with Public Health England and will seek to answer the remaining questions around how PrEP could be commissioned in the most cost effective and integrated way to reduce HIV and sexually transmitted infections in those at highest risk.
